망막분지정맥폐쇄에 합병된 황반부종에서 유리체강내 베바시주맙 주입과 격자광응고술 병합요법 = Combined Therapy of Bevacizumab and Grid Photocoagulation for Macular Edema in Branch Retinal Vein Occlusion

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate clinical outcomes of a combined therapy of intravitreal bevacizumab and grid laser photocoagulation for macular edema in branch retinal vein occlusion (BRVO). Methods: In the present retrospective study, medical records of patients who were treated with intravitreal bevacizumab injection for macular edema due to BRVO were reviewed. The eyes were divided into 2 groups, the combined therapy group of intravitreal bevacizumab and grid laser photocoagulation, and the monotherapy group of intravitreal bevacizumab. Visual acuity and central subfield macular thickness were investigated at 1, 2 and 6 months. Recurrence rate was compared between the 2 groups. Results: Among 49 eyes, 18 eyes underwent macular grid photocoagulation and 31 eyes did not receive laser treatment. Laser photocoagulation was performed at 1.2 months after injection on average. Visual acuity improved significantly at 2 and 6 months in the combined therapy group, and at 1, 2 and 6 months in the monotherapy group. Macular thickness decreased significantly compared to baseline at all visits in both groups. There was no significant difference in visual acuity and foveal thickness between the 2 groups. Recurrence at 6 months was significantly less frequent in the combined therapy group (3 eyes, 17%) then in the monotherapy group (14 eyes, 45%, p = 0.046). Conclusions: Combined grid photocoagulation after intravitreal bevacizumab injection lowered the recurrence rate of macular edema complicated with BRVO. J Korean Ophthalmol Soc 2012;53(10):1458-1464

참고문헌 (Reference)

1 이승욱, "분지망막정맥폐쇄에 합병된 황반부종에서 유리체강내 트리암시놀론 주입과 격자광응고술의 효과" 대한안과학회 50 (50): 704-709, 2009

2 Abeqq M, "Treatment of branch retinal vein occlusion induced macular edema with bevacizumab" 8 : 18-, 2008

3 Gutman FA, "The natural course of temporal retinal branch vein occlusion" 78 : 178-192, 1974

4 Weiter JJ, "The influence of the photoreceptor-RPE complex on the inner retina. An explanation for the beneficial effects of photocoagulation" 87 : 1133-1139, 1980

5 Klein R, "The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study" 98 : 133-141, 2000

6 Klein R, "The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study" 126 : 513-518, 2008

7 Magargal LE, "Temporal branch retinal vein obstruction: a review" 17 : 240-246, 1986

8 Lewen RM, "Subretinal neovascularization complicating laser photocoagulation of diabetic maculopathy" 19 : 734-737, 1988

9 Guyer DR, "Subretinal fibrosis after laser photocoagulation for diabetic macular edema" 113 : 652-656, 1992

10 Rutledge BK, "Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema" 111 : 608-613, 1993

11 Campochiaro PA, "Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study" 117 : 1102-1112, 2010

12 Schatz H, "Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema" 109 : 1549-1551, 1991

13 Mitchell P, "Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study" 114 : 1243-1247, 1996

14 Rosenfeld PJ, "Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion" 36 : 336-339, 2005

15 Jaissle GB, "One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion" 247 : 27-33, 2009

16 Hayreh SS, "Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion" 90 : 488-506, 1983

17 Striph GG, "Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visual field" 95 : 1673-1679, 1988

18 Arnarsson A, "Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion" 41 : 877-879, 2000

19 Arnarsson A, "Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion" 41 : 877-879, 2000

20 Roseman RL, "Krypton red laser photocoagulation for branch retinal vein occlusion" 94 : 1120-1125, 1987

21 Noma H, "Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion" 244 : 309-315, 2006

22 Gündüz K, "Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion" 22 : 1168-1171, 2008

23 Battaglia Parodi M, "Grid laser treatment in macular branch retinal vein occlusion" 237 : 1024-1027, 1999

24 Riese J, "Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion" 246 : 1671-1676, 2008

25 Wong TY, "Clinical practice. Retinal-vein occlusion" 363 : 2135-2144, 2010

26 Lewis H, "Choroidal neovascularization after laser photocoagulation for diabetic macular edema" 97 : 503-510, 1990

27 Rehak J, "Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities" 33 : 111-131, 2008

28 Silva RM, "Blood-retina barrier in acute retinal branch vein occlusion" 233 : 721-726, 1995

29 Stahl A, "Bevacizumab in retinal vein occlusion-results of a prospective case series" 245 : 1429-1436, 2007

30 Russo V, "Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion" 29 : 511-515, 2009

31 Morgan CM, "Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation" 96 : 96-103, 1989

32 "Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group" 98 : 271-282, 1984

33 "Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group" 98 : 271-282, 1984

34 Scott IU, "A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6" 127 : 1115-1128, 2009